Clinical Research Directory
Browse clinical research sites, groups, and studies.
Percutaneous Holmium Injection in Pancreatic Cancer
Sponsor: Radboud University Medical Center
Summary
This investigator initiated study with a medical device aims to assess the safety and feasibility of percutaneous injected holmium-166 microsphere brachytherapy in patients with irresectable pancreatic cancer.
Official title: Percutaneous Intratumoural Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer; a Single Centre, Prospective Safety and Feasibility Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
6
Start Date
2023-05-01
Completion Date
2025-04-22
Last Updated
2025-02-11
Healthy Volunteers
No
Conditions
Interventions
Intratumoral
Comparable to CE-marked QuiremSpheres(R) outside of intended use with minor altered specification.
Locations (1)
Radboud University Medical Centre
Nijmegen, Gelderland, Netherlands